OBJECTIVE: Cell-based therapies are being investigated as an adjunct to IV thrombolysis or mechanical thrombectomy in ischemic stroke. This review summarizes the potential applications as well as challenges of intravascular cell delivery in ischemic stroke. METHOD: We conducted a search of Medline as well as the clinicaltrials.gov Web site for all ongoing human clinical studies using stem cells in ischemic stroke patients. RESULT: The pros and cons of the various donor cell types and routes of cell delivery, including intravascular delivery, in ischemic stroke are discussed. In addition, the potential challenges in translation from bench to bedside, the optimal techniques for intravascular cell delivery, and an updated comprehensive list of ongoing clinical trials in ischemic stroke are highlighted. CONCLUSIONS: Stem cells have shown a promising role in ischemic stroke, in preclinical studies as well as initial pilot studies. Further studies are needed to assess intravascular cell therapy as a potential adjunct to thrombolysis or mechanical thrombectomy in ischemic stroke.
OBJECTIVE: Cell-based therapies are being investigated as an adjunct to IV thrombolysis or mechanical thrombectomy in ischemic stroke. This review summarizes the potential applications as well as challenges of intravascular cell delivery in ischemic stroke. METHOD: We conducted a search of Medline as well as the clinicaltrials.gov Web site for all ongoing human clinical studies using stem cells in ischemic strokepatients. RESULT: The pros and cons of the various donor cell types and routes of cell delivery, including intravascular delivery, in ischemic stroke are discussed. In addition, the potential challenges in translation from bench to bedside, the optimal techniques for intravascular cell delivery, and an updated comprehensive list of ongoing clinical trials in ischemic stroke are highlighted. CONCLUSIONS: Stem cells have shown a promising role in ischemic stroke, in preclinical studies as well as initial pilot studies. Further studies are needed to assess intravascular cell therapy as a potential adjunct to thrombolysis or mechanical thrombectomy in ischemic stroke.
Authors: S S Rabinovich; V I Seledtsov; N V Banul; O V Poveshchenko; V V Senyukov; S V Astrakov; D M Samarin; V Ya Taraban Journal: Bull Exp Biol Med Date: 2005-01 Impact factor: 0.804
Authors: Olivier Hauger; Emma E Frost; Ruud van Heeswijk; Colette Deminière; R Xue; Yahsou Delmas; Christian Combe; Chrit T W Moonen; Nicolas Grenier; Jeff W M Bulte Journal: Radiology Date: 2006-01 Impact factor: 11.105
Authors: Peter A Walker; Phillip A Letourneau; Supinder Bedi; Shinil K Shah; Fernando Jimenez; Charles S Cox Journal: World J Stem Cells Date: 2011-02-26 Impact factor: 5.326
Authors: Vallabh Janardhan; Alessandra Biondi; Howard A Riina; Pina C Sanelli; Philip E Stieg; Y Pierre Gobin Journal: Neuroimaging Clin N Am Date: 2006-08 Impact factor: 2.264
Authors: R El Khoury; V Misra; S Sharma; C S Cox; P Walker; J C Grotta; A Gee; S Suzuki; S I Savitz Journal: AJNR Am J Neuroradiol Date: 2010-04-15 Impact factor: 3.825
Authors: Valeria Battistella; Gabriel R de Freitas; Lea Mirian Barbosa da Fonseca; Daniel Mercante; Bianca Gutfilen; Regina C S Goldenberg; Juliana Vieira Dias; Tais H Kasai-Brunswick; Eduardo Wajnberg; Paulo Henrique Rosado-de-Castro; Soniza V Alves-Leon; Rosalia Mendez-Otero; Charles Andre Journal: Regen Med Date: 2011-01 Impact factor: 3.806
Authors: Sean I Savitz; Vivek Misra; Mallik Kasam; Harrinder Juneja; Charles S Cox; Susan Alderman; Imo Aisiku; Siddhartha Kar; Adrian Gee; James C Grotta Journal: Ann Neurol Date: 2011-07 Impact factor: 10.422
Authors: Eugenia R Nuzzolo; Sara Capodimonti; Maurizio Martini; Maria G Iachininoto; Maria Bianchi; Alessandra Cocomazzi; Gina Zini; Giuseppe Leone; Luigi M Larocca; Luciana Teofili Journal: Blood Transfus Date: 2013-06-19 Impact factor: 3.443